Skip to search formSkip to main contentSkip to account menu

stepronin

Known as: Stepronino, prostenoglycine, 2-(alpha-thenoylthio)propionylglycine 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Antiviral AgentsExpectorantsGlycineImmunosuppressive Agents

Narrower (2)

TS 5010680Tiase
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Generative models for pictures tiled by triangles
The problem of generation of triangle-tiled pictures that are two-dimensional figures tiled by isosceles right triangles of the… 
2010
2010
Effects of sulphurous water on human neutrophil elastase release
Background: Molecules bearing a sulphide (HS) group, such as glutathione, play a fundamental role in the defensive system of… 
1996
1996
Accelerated cell‐mediated broncho‐obstructive reaction to inhaled stepronin: a case report
We describe the case of a 20‐year‐old man who developed an obstructive bronchial reaction accompanied by a maculopapular facial… 
1994
1994
An expectorant, stepronin, reduces airway secretion in vitro.
Stepronin (SPN) is clinically used as an expectorant, and thenoic acid (TA) is its metabolite. We examined the effects of these… 
1993
1993
Delayed hypersensitivity to stepronin: a case report
1991
1991
High-performance liquid chromatographic evaluation of 2-(alpha-thenoylthio)propionylglycine and its two metabolites in biological fluids.
1987
1987
Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
To investigate the characteristics of bronchial mucus in bronchopneumopathic patients before and after stepronine-lysine salt… 
1985
1985
A new mucotropic agent--in vitro and in vivo evaluation of 2-alpha-thenoylthiopropionylglycine (bronchoplus).
A new mucotropic agent, 2-alpha-thenoylthiopropionylglycine (TTPG) has been evaluated using two in vitro mucus models (pig… 
1982
1982
[The therapeutic activity of stepronin in viral hepatitis].
The therapeutic effect of stepronin in 5% glucosate solution has been evaluated in 55/110 viral hepatitis cases (10/55 of A type… 
1981
1981
[Protective action of prostenoglycine in in-vitro experimental erythrocyte poisoning].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)